• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 06/04/2024
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2024, a percival valve size m was implanted.After de-clamped, abnormality and bleeding were noted by echo, thus, the valve was directly observed, and tissue damage was observed near the mitral valve just below annulus.Since the patient seemed weak, it had been reinforced with thread before percival implantation.But the reinforcement was damaged during deployment and ballooning, leading to hemorrhage.The implanted percival valve was removed and replaced with a 19mm inspris instead.
 
Additional Manufacturer Narrative
The manufacturing and material records for the device and nitinol stent involved in this event, as they pertain to the reported issue, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this prosthesis and its component satisfied all required material, visual, and performance standards at the time of manufacture and release.A follow up report will be provided upon receipt of any further information.
 
Additional Manufacturer Narrative
Based on the available information, the root cause of the event could not be established.Since the explanted device was not returned to the manufacturer, further investigation on the device could not be performed.However, there are no deficits noted during the manufacturing records review for the device.Based on the information available, the cause of the event was related to the procedural difficulties.Should further information be received in the future, a follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Common Device Name
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key19675055
Report Number3004478276-2024-00147
Device Sequence Number15391302
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)270317
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P150011
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/04/2024
Supplement Date Received by Manufacturer12/31/2024
Initial Report FDA Received Date07/04/2024
Supplement Report FDA Received Date12/31/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/17/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
Patient SexMale
-
-